Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|15|8|738-778

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.8, 2014-08, pp. : 738-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase: An Interface Connecting Cognitive Deficits to Neuropsychiatric and Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 303-316

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemical and Pharmacological Aspects of Imidazole-Containing Histamine H3 Receptor Antagonists

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-11 ,pp. : 965-977

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical treatment for cognitive deficits in Alzheimer’s disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps

By Bartus Raymond   Dean Reginald  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 15-36

Springer Publishing Company

Access to resources Recommend Favorite

Preattentional and attentional cognitive deficits as targets for treating schizophrenia

By Braff David   Light Gregory  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite